ROCHESTER, N.Y., Feb. 29, 2016 /PRNewswire/ -- VirtualScopics,
Inc. (NASDAQ:VSCP), a leading provider of clinical trial imaging
solutions, today announced that it will report its 2015 fourth
quarter and full year financial results before the markets open on
Wednesday, March 30, 2016.
Eric T. Converse, president and
chief executive officer, and Jim
Groff, chief financial officer, will host a conference call
and webcast to discuss the company's financial results and provide
a business update at 8:30 a.m. ET
that morning. The conference call and webcast information are
as follows:
Domestic Call Dial
In: 877-407-8035
|
International Call
Dial In: 201-689-8035
|
Conference Call
ID: 13631781
|
An accompanying slide presentation to enhance managements'
formal remarks, as well as a webcast of the call, can be accessed
at the following links:
http://virtualscopics.investorroom.com/webcasts
or
|
http://www.investorcalendar.com/IC/CEPage.asp?ID=174758.
|
A replay and slide presentation will be available one hour after
the conclusion of the conference call for 90 days, and can be
accessed accordingly:
Replay Domestic Dial
In: 877-660-6853
|
Replay International
Dial In: 201-612-7415
|
Replay Conference
Call ID: 13631781
|
The webcast and slide presentation can be accessed at the
following links:
http://virtualscopics.investorroom.com/webcasts
or
|
http://www.investorcalendar.com/IC/CEPage.asp?ID=174758.
|
About VirtualScopics, Inc.
VirtualScopics, Inc.
(NASDAQ:VSCP) is a leading imaging CRO/Central reader, providing
clinical trial imaging solutions to accelerate drug development.
Medical and scientific expertise, operational flexibility and
responsiveness are hallmarks of our daily work and collaborative
approach. We understand the risks and time constraints that
clinical trial study teams, medical directors, radiologists,
and imaging scientists face. We focus on addressing these
challenges by consistently delivering quality imaging data and
imaging services on time and within budget. It's these exceptional
performance advantages that truly set our clinical trial imaging
services apart. For more information about VirtualScopics,
Inc., please visit www.virtualscopics.com.
Forward-looking Statements
The statements contained in
this press release that are not purely historical are
forward-looking statements within the meaning of the Section 27A of
the Securities Act of 1933, as amended, and Section 21E of the
Securities Exchange Act of 1934, as amended, and are intended to be
covered by the safe harbors created thereby. These
forward-looking statements include, but are not limited to,
statements regarding continued positive Adjusted EBITDA, the
expected benefits of the Company's investment in infrastructure,
sales and marketing efforts, the increase in backlog, awards and
bookings and the performance of existing projects and/or statements
preceded by, followed by or that include the words "believes",
"could", "expects", "anticipates", "estimates", "intends", "plans",
"projects", "seeks", or similar expressions. Forward-looking
statements deal with the company's current plans, intentions,
beliefs and expectations. Investors are cautioned that all
forward-looking statements involve risks and uncertainties that
could cause actual results to differ materially from those in the
forward-looking statements. Many of these risks and
uncertainties are discussed in the company's Annual Report on Form
10-K for the fiscal year ended December 31,
2014 filed with the Securities and Exchange Commission (the
"SEC"), and in any subsequent reports filed with the SEC,
all of which are available at the SEC's website at
www.sec.gov. These include without limitation: the risk of
cancellation or delay of customer contracts or that contract awards
do not turn into signed contracts. Other risks include the
company's dependence on its largest customers and risk of contract
performance, protection of our intellectual property and the risks
of infringement on the intellectual property rights of
others. All forward-looking statements speak only as of the
date of this press release and the company undertakes no obligation
to update such forward-looking statements.
For More Information, Contact:
Donna N. Stein, APR, Fellow PRSA
Managing Partner
Donna Stein & Partners
315-361-4672
Email: dstein1@twcny.rr.com
To view the original version on PR Newswire,
visit:http://www.prnewswire.com/news-releases/virtualscopics-inc-schedules-2015-fourth-quarter-and-full-year-financial-results-press-release-conference-call-and-webcast-300227736.html
SOURCE VirtualScopics, Inc.